One trial found that people on Ozempic went on longer walks. There's a Morgan Stanley survey that found that patients on GLP-1s ate 60% less candy and 40% more vegetables. It seems to reduce smoking for smoking addicts, gambling for gambling addicts, and even for some compulsive nail-biting.